Cell line · CVCL_0546
Papers280
1 to 20 of 280
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Fatty acid-binding protein 2 suppresses liver metastasis by cytoplasmic sequestration of β-catenin to enhance ferroptosis sensitivity in colon cancer. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PSY Inhibits Colorectal Cancer Growth and Exhibits an In Vitro Synergistic Interaction with 5-Fluorouracil. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cross-Dataset Genomic Proximity and Functional Association of FOXA1 and TET2 at Hypomethylated Regulatory Regions in Colorectal Cancer. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cytotoxicity and α-Amylase Inhibitory Activities of Limonoids From the Leaves of Azadirachta indica. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MIIP Inhibits Colorectal Cancer Progression by Modulating Neutrophils Infiltration and Neutrophil Extracellular Trap Formation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intratumoral Bacillus regulating colorectal cancer liver metastasis: links to lipid metabolism and APOE+ macrophages. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Mechanism Underlying Inhibition of Colorectal Cancer Invasion by Quxie Capsule Through CRK-RAC Signaling Pathway Regulation. | Integr Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic-cell-death gene trio predicts survival and cuproptosis sensitivity in colorectal cancer. | J Gastrointest Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer. | Cancer Drug Resist | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer. | Mol Ther Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti-PD-1 Immunotherapy. | Can J Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues. | Stem Cell Reports | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Tale of Two Cell Lines: Characterization of Differential Efficacy of Small Molecule Drugs Cediranib and NU-7441 on Primary Versus Metastatic Colorectal Cancer. | Pharmacol Res Perspect | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FUT2-Mediated Fucosylation of OLFM4 Promotes Colon Cancer Cell Differentiation. | Can J Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0546/papers